查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511931

胰岛素笔市场规模、份额和趋势分析报告：按类型、最终用途、地区、细分市场预测，2024-2030 年

Insulin Pens Market Size, Share & Trends Analysis Report By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare, Others), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

胰岛素笔市场成长与趋势：

Grand View Research最新报告显示，预计到2030年，全球胰岛素笔市场规模将达到124.1亿美元。预计 2024 年至 2030 年期间复合年增长率将达到 8.08%。推动市场成长的主要因素是全球糖尿病盛行率的上升。根据国际糖尿病联盟的数据，2021 年约有 5.37 亿成年人患有糖尿病，预计到 2030 年将增加至 6.43 亿人。这一不断增长的数字极大地刺激了对有效且方便的胰岛素输送方法（例如胰岛素笔）的需求。

该国际协议旨在 2025 年遏止糖尿病和肥胖症的上升。目前，全球约 4.22 亿糖尿病患者中的大多数居住在低收入国家，其中 2 型糖尿病每年导致 150 万人死亡。近几十年来，糖尿病盛行率稳定上升。根据IDF糖尿病图谱的最新资料，全球糖尿病盛行率为10.5%，其中近44.7%的人未被诊断。根据IDF未来预测，到2045年，成年糖尿病患者人数可能达到7.83亿，约占全球人口的12.5%，成长46%。这一成长趋势远超过同期世界人口20%的预期成长率。

胰岛素笔技术的进步、老年人口的增加以及各地区医疗基础设施投资的增加对于市场扩张至关重要。此外，相对于传统注射器和管瓶，向现代胰岛素输送设备的转变在市场扩张中发挥关键作用。然而，市场面临挑战，例如胰岛素笔治疗的​​高成本以及新兴国家有限的报销政策。儘管存在这些障碍，研究和开发工作仍在进行中，以推出创新且具有成本效益的胰岛素笔，并有望克服这些障碍。

胰岛素笔全球市场报告亮点

  • 按类型划分，胰岛素笔市场分为一次性胰岛素笔和可重复使用胰岛素笔，其中一次性笔因其方便和卫生的优点而占据最大的市场占有率。
  • 依最终用途划分，胰岛素笔市场分为医院和诊所、居家照护等。其中，居家照护领域占最大市场占有率， 2023年为48.21%。
  • 此外，由于医疗基础设施完善、糖尿病盛行率高以及市场领导者的强大影响力，北美胰岛素笔市场在 2023 年占据主导地位，收益占有率最高，达到 40.73%。
  • 受中国和印度等新兴经济体医疗保健支出增加、糖尿病意识提高以及医疗保健设施改善的推动，预计亚太地区在预测期内将实现 8.8% 的最快增长率 (CAGR)。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章胰岛素笔市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 胰岛素笔市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章胰岛素笔市场：类型估计和趋势分析

  • 细分仪表板
  • 全球胰岛素笔市场波动分析
  • 2018-2030年全球胰岛素笔市场规模及趋势分析（按类型）
  • 可重覆使用胰岛素笔
  • 抛弃式胰岛素笔

第五章胰岛素笔市场：最终用途估计和趋势分析

  • 细分仪表板
  • 全球胰岛素笔终端用途市场波动分析
  • 2018-2030 年全球胰岛素笔市场规模与趋势分析（依最终用途）
  • 医院/诊所
  • 居家护理
  • 其他的

第六章胰岛素笔市场：按产品、应用、模式和最终用途的区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2023年主要企业市场占有率分析
  • Company Position Analysis
  • 公司分类（新兴企业、创新企业、领导者）
  • 公司简介
    • Medtronic Plc
    • Novo Nordisk A/S
    • Sanofi
    • Eli Lilly and Company
    • Ypsomed AG
    • Insulet Corporation
    • B. Braun SE
    • Owen Mumford Ltd.
    • Tandem Diabetes Care, Inc.
Product Code: GVR-4-68040-302-6

Insulin Pens Market Growth & Trends:

The global insulin pens market size is anticipated to reach USD 12.41 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.08% during the forecast period, 2024 to 2030. Key drivers propelling market growth include rising prevalence of diabetes worldwide. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a number expected to rise to 643 million by 2030. This escalating figure has significantly fueled the demand for effective and convenient insulin delivery methods, such as insulin pens.

The international agreement aims to stop the rise of diabetes and obesity by 2025. Currently, the majority of the global diabetic population of approximately 422 million resides in lower-income countries, contributing to 1.5 million deaths annually due to type 2 diabetes. Over recent decades, there has been a steady increase in diabetes rates. The latest data from the IDF Diabetes Atlas indicates a global diabetes prevalence rate of 10.5%, with nearly 44.7% of cases remaining undiagnosed. Future forecasts from the IDF suggest that by 2045, the number of adults with diabetes could reach 783 million, or roughly 12.5% of the global population, marking a 46% increase. This uptrend significantly outpaces the anticipated global population growth of 20% for the same timeframe.

Advancements in insulin pen technology, the growing geriatric population, and increasing investments in healthcare infrastructure across various regions have been crucial in market expansion. Furthermore, the shift towards modern insulin delivery devices over traditional syringes and vials has played a pivotal role in market expansion. However, the market faces challenges such as high costs associated with insulin pen therapy and limited reimbursement policies in developing countries. Despite these barriers, ongoing research and development efforts to introduce innovative, cost-effective insulin pens are anticipated to overcome these hurdles.

Global Insulin Pens Market Report Highlights:

  • By type, the insulin pens market is categorized into disposable and reusable insulin pens, with disposable pens holding the largest market share due to their convenience and hygiene benefits
  • By end use, the insulin pens market is segmented into hospitals & clinics, homecare, and others. Among these, homecare segment captured the largest market share of 48.21% in 2023
  • Furthermore, North America insulin pens market dominated the market by capturing the highest revenue share of 40.73% in 2023 owing to its well-established healthcare infrastructure, high diabetes prevalence, and strong presence of leading market players
  • The Asia Pacific region is expected to witness the fastest growth rate (CAGR) of 8.8% during the forecast period, driven by increasing healthcare expenditure, rising diabetes awareness, and improving healthcare facilities in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Pens Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in the prevalence of diabetes globally
      • 3.2.1.2. Advancements in technology and development of smart insulin pens
      • 3.2.1.3. Growing awareness and education about diabetes management
      • 3.2.1.4. Increasing government initiatives and support to provide accessible and affordable diabetes treatment
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of smart insulin pens
      • 3.2.2.2. Lack of awareness and education about advanced diabetes management tools
      • 3.2.2.3. Stringent regulatory approvals
  • 3.3. Insulin Pens Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Insulin Pens Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Insulin Pens Type Market Movement Analysis
  • 4.3. Global Insulin Pens Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Reusable Insulin Pens
    • 4.4.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Disposable Insulin Pens
    • 4.5.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Insulin Pens Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Insulin Pens End Use Market Movement Analysis
  • 5.3. Global Insulin Pens Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Insulin Pens Market: Regional Estimates & Trend Analysis By Product , Application, Modality, End Use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2023
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. Medtronic Plc
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Novo Nordisk A/S
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Sanofi
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Eli Lilly and Company
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Ypsomed AG
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Insulet Corporation
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. B. Braun SE
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Owen Mumford Ltd.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Tandem Diabetes Care, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 5 North America insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 7 U.S. insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 9 Canada insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Mexico insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 11 Mexico insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 13 Europe insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 14 Europe insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 15 UK insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 16 UK insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 18 Germany insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 19 France insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 20 France insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 22 Italy insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 24 Denmark insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 26 Sweden insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 28 Norway insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Japan insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 33 Japan insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 34 China insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 35 China insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 36 India insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 37 India insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Australia insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 39 Australia insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 41 South Korea insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 43 Thailand insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America insulin pens market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Latin America insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 46 Latin America insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 48 Brazil insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 49 Argentina insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 50 Argentina insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 52 Middle East & Africa insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 South Africa insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 55 South Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 58 UAE insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 59 UAE insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait insulin pens market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Insulin pens market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Insulin pens market driver impact
  • Fig. 19 Insulin pens market restraint impact
  • Fig. 20 Insulin pens market: Type movement analysis
  • Fig. 21 Insulin pens market: Type outlook and key takeaways
  • Fig. 22 Reusable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 23 Disposable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 24 Insulin pens market: End use movement analysis
  • Fig. 25 Insulin pens market: End use outlook and key takeaways
  • Fig. 26 Hospitals and clinics market estimates and forecast, 2018 - 2030
  • Fig. 27 Homecare market estimates and forecast, 2018 - 2030
  • Fig. 28 Others end users market estimates and forecast, 2018 - 2030
  • Fig. 29 Global insulin pens market: Regional movement analysis
  • Fig. 30 Global insulin pens market: Regional outlook and key takeaways
  • Fig. 31 North America
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030
  • Fig. 33 U.S.
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 35 Canada
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 37 Mexico
  • Fig. 38 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 39 Europe
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 41 UK
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 45 France
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 55 Norway
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 57 Asia Pacific
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 59 China
  • Fig. 60 China market estimates and forecasts, 2018 - 2030
  • Fig. 61 Japan
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 63 India
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Thailand
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 67 South Korea
  • Fig. 68 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 69 Australia
  • Fig. 70 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 71 Latin America
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 73 Brazil
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Mexico
  • Fig. 76 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 77 Argentina
  • Fig. 78 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 79 Middle East and Africa
  • Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 81 South Africa
  • Fig. 82 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 83 Saudi Arabia
  • Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 85 UAE
  • Fig. 86 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 87 Kuwait
  • Fig. 88 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 89 Market share of key market players- Insulin pens market